ArticleJournal of the American College of Emergency Physicians open2026
Serum Magnesium Levels as a Prognostic Marker in Emergency Department Admissions: A Landmark Retrospective Cohort Study.
Article in Journal of the American College of Emergency Physicians open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Early identification of serious hypermagnesemia in emergency department (ED) patients is challenging due to limited clinical information and unknown baseline factors. Our institution implemented routine serum magnesium (Mg) testing for all ED patients to prevent missed diagnoses of fatal hypermagnesemia. We evaluated whether these measurements improved short-term prognostic assessment by associating with 28-day all-cause mortality. Methods: We conducted a retrospective cohort study of 43,100 adult ED admissions at a tertiary center in Japan from January 2017 to December 2019; 12,580 met the eligibility criteria. Patients were stratified according to Mg levels: hypomagnesemia (<1.6 mg/dL; n = 433), normomagnesemia (1.6-2.4 mg/dL; n = 10,722), and hypermagnesemia (≥2.5 mg/dL; n = 1425). The primary outcome was 28-day all-cause mortality. Multivariable analyses were adjusted for age, sex, admission diagnosis, admission to the intensive care unit, albumin, C-reactive protein (CRP), and other laboratory covariates. Restricted cubic spline analysis was used to assess nonlinear associations. Results: The model adjusted for patients' characteristics showed higher mortality rates in hypomagnesemia and hypermagnesemia. Spline analysis initially revealed a U-shaped relationship between Mg levels and 28-day mortality. However, the risk associated with hypomagnesemia was attenuated after additional adjustments for CRP and albumin levels, whereas hypermagnesemia remained independently associated with 28-day mortality (adjusted hazard ratio, 1.73; 95% CI 1.51-2.00). This association remained consistent after stratification by renal function or admission diagnosis. Conclusion: Systematic Mg testing in the ED may facilitate the early identification of patients at imminent risk. Routine Mg assessment could help clinicians recognize high-risk patients in acute care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.